Genetic variation in the B7-1 gene in patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 105, Issue 2, 2000, Pages 184-188

  Weinshenker, Brian G ^a   Hebrink, David D ^a   Klein, Christopher ^a   Atkinson, Elizabeth J ^a   O'Brien, Peter C ^a   McMurray, Cynthia T ^a  

^a MAYO CLINIC   (United States)

Author keywords

Association; B7 1; Genetics; Multiple sclerosis; Prognosis

Indexed keywords

B7 ANTIGEN;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS;

3' UNTRANSLATED REGIONS; ANTIGENS, CD80; HUMANS; MULTIPLE SCLEROSIS; VARIATION (GENETICS);

EID: 0034717833     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00197-1     Document Type: Article

References (23)

1. Brassat D., Azais-Vuillemin C., Yaouanq J., Semana G., Reboul J., Cournu I., Mertens C., Edan G., Lyon-Caen O., Clanet M., Fontaine B. Familial factors influence disability in MS multiplex families. French multiple sclerosis genetics group. Neurology. 52:1999;1632-1636.
2. Compston A. Genetic epidemiology of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 62:1997;553-561.
3. Guerder S., Meyerhoff J., Flavell R. The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity. 1:1994;155-166.
4. Harlan D., Hengartner H., Huang M., Kang Y., Abe R., Moreadith R., Pircher H., Gray G., Ohashi P., Freeman G. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T Cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc. Natl. Acad. Sci. USA. 91:1994;3137-3141.
5. Higuchi R. Recombinant PCR. Innis M., Gelfand D., Sninsky J., White T. PCR Protocols: A Guide to Methods and Applications. 1990;177-183 Academic Press, San Diego.
6. Liu Q., Sommer S. Parameters affecting the sensitivities of dideoxyfingerprinting and SSCP. PCR Methods Appl. 4:1994;97-108.
7. Myhr K., Raknes G., Nyland H., Vedeler C. Immunoglobulin G Fc-receptor (Fc γ R) II A and III B polymorphisms related to disability in MS. Neurology. 52:1999;1771-1776.
8. Navikas V., Link H. Review: cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:1996;322-333.
9. Olerup O., Hillert J., Fredrikson S., Olsson T., Kam-Hansen S., Möller E., Carlsson B., Wallin J. Primarily chronic progressive and relapsing/remitting multiple sclerosis: Two immunogenetically distinct disease entities. Proc. Natl. Acad. Sci. USA. 86:1989;7113-7117.
10. Reiser H., Stadecker M.J. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. New England J. Med. 335:(18):1996;1369-1377.
11. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
12. Robertson N.P., Clayton D., Fraser M., Deans J., Compston D.A. Clinical concordance in sibling pairs with multiple sclerosis. Neurology. 47:(2):1996;347-352.
13. Rodriguez M., Siva A., Ward J., Stolp-Smith K., O'Brien P., Kurland L. Impairment, disability, and handicap in multiple sclerosis: A population-based study in Olmsted County, Minnesota. Neurology. 44:1994;28-83.
14. Sadovnick A., Dyment D., Ebers G. Genetic epidemiology of multiple sclerosis. Epidemiol. Rev. 19:1997;99-106.
15. Schrijver H., Crusius J., Uitdehaag B., Garcia Gonzalez M., Kostense P., Polman C., Pena A. Association of interleukin-1 beta and interleukin-1 receptor antagonist genes with disease severity in MS. Neurology. 52:1999;595-599.
16. Selvakumar A., Mohanraj B., Eddy R., Shows T., White P., Dupont B. Genomic organization and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7. Immunogenetics. 36:(3):1992;175-181.
17. Shaw G., Kamen R. A conserved AU sequence from the 3′-untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:1986;659-667.
18. Sobell J., Heston L., Sommer S. Delineation of genetic predisposition to multifactorial disease: a general approach on the threshold of feasibility. Genomics. 12:1992;1-6.
19. Sommer S., Groszbach A., Bottema C. PCR amplification of specific alleles (PASA) is a general method for rapidly detecting known single-base changes. BioTechniques. 12:1992;82-87.
20. Van Parijs L., Abbas A.K. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 280:(5361):1998;243-248.
21. Weinshenker B.G., Wingerchuk D.M., Liu Q., Bissonet A.S., Schaid D.J., Sommer S.S. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology. 49:(2):1997;378-385.
22. Weinshenker B.G., Santrach P., Bissonett A.S., McDonnell S.K., Schaid D., Moore S.B., Rodriguez M. Major histocompatibility complex class II alleles and the course of multiple sclerosis: A population-based study. Neurology. 51:1998;742-747.
23. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe M., Cuzner M., Hafler D. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:(6):1995;1985-1996.